Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
template_treatment [2025/02/24 16:35] – jkohts | template_treatment [2025/05/06 01:29] (current) – jkohts | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== Title: Drug (treatment) ====== | + | ====== Title: Drug (Treatment) ====== |
===== - Overview ===== | ===== - Overview ===== | ||
+ | ===== - Toxicologic Indications & Dosing ===== | ||
- | ===== - Toxicologic indications & dosing ===== | + | ==== - Indication 1 ==== |
- | ==== - Adult ==== | + | |
- | **Indication 1 (e.g. Symptom/ | + | * **Adult:** |
- | * 💊 DrugName Dose Route, Frequency. | + | * 💊 **DrugName Dose Route**, Frequency. |
- | * 💊 DrugName Dose Route, Frequency. | + | |
+ | | ||
* Other notes if applicable. | * Other notes if applicable. | ||
- | **Indication 2 (e.g. Symptom/ | + | ==== - Indication 2 ==== |
- | * 💊 DrugName Dose Route, Frequency. | + | |
- | * 💊 DrugName Dose Route, Frequency. | + | * Also see: [[: |
+ | * **Adult:** | ||
+ | * 💊 **DrugName Dose Route**, Frequency. | ||
+ | * 💊 **DrugName Dose Route**, Frequency. | ||
+ | | ||
+ | | ||
+ | * 💊👶 **DrugName Dose Route**, Frequency. | ||
* Other notes if applicable. | * Other notes if applicable. | ||
+ | ==== - Indication 3 ==== | ||
- | ==== - Pediatric ==== | + | |
- | **Indication 1 (e.g. Symptom/ | + | * **Adult: |
- | * 💊👶 DrugName Dose Route, Frequency. | + | * **Child: |
- | * 💊👶 DrugName Dose Route, Frequency. | + | |
* Other notes if applicable. | * Other notes if applicable. | ||
- | **Indication 2 (e.g. Symptom/ | + | ===== - Cautions & Contraindications ===== |
- | * 💊👶 DrugName Dose Route, Frequency. | + | |
- | * 💊👶 DrugName Dose Route, Frequency. | + | |
- | * Other notes if applicable. | + | |
+ | ===== - Special Populations ===== | ||
- | ===== - Cautions & contraindications ===== | ||
- | |||
- | |||
- | ===== - Special populations ===== | ||
**Pregnancy rating:** | **Pregnancy rating:** | ||
Line 42: | Line 44: | ||
**Hepatic impairment: | **Hepatic impairment: | ||
+ | ===== - Adverse Effects ===== | ||
- | ===== - Adverse effects ===== | ||
* Description of important/ | * Description of important/ | ||
- | * Serotonin syndrome: | + | * Serotonin syndrome: |
- | * Systems e.g. | + | * Systems e.g. |
* **GI:** | * **GI:** | ||
* **Resp:** | * **Resp:** | ||
- | * **MSK:** local phlebitis | + | * **MSK: |
* Frequency e.g. | * Frequency e.g. | ||
* **Common:** | * **Common:** | ||
- | |||
- | |||
===== - Pharmacology ===== | ===== - Pharmacology ===== | ||
==== - Pharmacodynamics ==== | ==== - Pharmacodynamics ==== | ||
+ | |||
**Mechanism of action:** | **Mechanism of action:** | ||
Line 62: | Line 63: | ||
**Absorption: | **Absorption: | ||
+ | |||
* Oral bioavailability: | * Oral bioavailability: | ||
* GI tract absorption: | * GI tract absorption: | ||
Line 67: | Line 69: | ||
**Distribution: | **Distribution: | ||
+ | |||
* Vd: | * Vd: | ||
+ | * Lipid solubility: | ||
+ | * Crosses/ | ||
+ | * Crosses/ | ||
+ | * Excreted/ | ||
* Protein binding: | * Protein binding: | ||
* Tmax: | * Tmax: | ||
Line 74: | Line 81: | ||
**Excretion: | **Excretion: | ||
+ | |||
* Elimination t½: | * Elimination t½: | ||
* Hepatic clearance: | * Hepatic clearance: | ||
Line 79: | Line 87: | ||
==== - Pharmaceutics ==== | ==== - Pharmaceutics ==== | ||
+ | |||
**Formulation: | **Formulation: | ||
- | |||
===== - References ===== | ===== - References ===== | ||
+ | |||
Useful general references: | Useful general references: | ||
~~REFNOTES~~ | ~~REFNOTES~~ | ||
+ | |||
+ |